Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / GMED - Globus Medical: NuVasive Merger Unlocks Incremental NOPAT Growth

GMED - Globus Medical: NuVasive Merger Unlocks Incremental NOPAT Growth

Globus Medical Inc. Class A

2024-06-15 08:21:30 ET

Summary

  • Globus Medical faced market backlash post-merger with NuVasive, but Q1 FY 2024 showed strong growth and integration efforts.
  • Management revised net sales guidance for FY 2024, aiming for high growth and increased profits with lower operating costs.
  • Valuation scenarios suggest potential for risk capital unlock, and a buy rating is supported on fundamentals and cash flow estimates.

Investment Summary

Investors were quick to punish Globus Medical ( GMED ) following its merger with NuVasive in 2023, quickly selling down the company's market value to the $45 per share range before it found a bottom. It now trades in the $65s after a number of recent developments....

For further details see:

Globus Medical: NuVasive Merger Unlocks Incremental NOPAT Growth
Stock Information
Company Name: Globus Medical Inc. Class A
Stock Symbol: GMED
Market: NYSE
Website: globusmedical.com
Menu
GMED GMED Quote GMED Short GMED News GMED Articles GMED Message Board
Get GMED Alerts

News, Short Squeeze, Breakout and More Instantly...